National and Kapodistrian University of Athens
Αξιολόγηση νεοτέρων βιοχημικών δεικτών σε παιδιά με καρκίνο και εμπύρετη ουδετεροπενία
Abstract
dc:descriptionPurpose: Febrile neutropenia among pediatric cancer patientsrequires prompt, efficient and efficacious clinical management. Theidentification, upon the onset of a febrile episode, of neutropenic cancerpatients with high risk for severe bacterial infection is vital. This thesisexamines several biochemical markers, that may have prognostic valuein identifying severe bacterial infection among neutropenic pediatriccancer patients.Methods: We enrolled 17 pediatric cancer patients (12 boys), age9 months to 14 years (median age 68,3 months) admitted to theOncology Department with fever (>38oC) and neutropenia(ANC<500/μl) presenting with a total of 20 neutropenic febrile episodes.We also enrolled 20 control patients (11 boys), age 3 months to 14years (median age 43,3 months) admitted to the pediatric clinic withacute fever (>38oC). We measured C-reactive protein (CRP),procalcitonin (PCT), macrophage migration inhibitory factor (MIF) andlipocalin (NGAL) upon admission and 2 days later and held a record ofWBC, ANC, results from blood and urine cultures. Exlusion criteria included patients with primary immunodeficiency, patients transplantedin first or subsequent remission as well as non-neutropenic cancerpatients, and patients on antibiotics prior to admission. Oncologypatients were divided into two groups based on diagnosis of febrileepisode; 1. severe bacterial infection (invasive or focal) and 2. viralinfection or fever of unknown origin (FUO). Control patients weredivided into three groups based on diagnosis of febrile episode:1. severe invasive bacterial infection, 2. focal bacterial infection, 3. viralinfection or FUO. For the measurement of biochemical markerssensitive immunoassay methods were used. For CRP immuneturbidimetry,for PCT LIA, for MIF ELISA and for NGAL rapid ELISA. The results were analysed using x2-test and non parametric methods,Wilcoxon's test between groups and Mann-Whitney, Wilcoxon's SignedRanks test for pairs inside each group and between measurements.Results: Measurements of PCT upon admission (t0) and 2 dayslater (t2) were significantly higher in cancer patients with proven severebacterial infection to those with viral infection or FUO (p=0,006 andp=0,011, respectively). Measurements of MIF upon admission (t0) andNGAL 2 days later (t2) were also significantly higher in cancer patientswith severe bacterial infection to those with viral infection or FUO(p=0,026 and p=0,026, respectively). CRP measurements were notstatistically significant in differentiating between severity of disease. Inthe control group only measurements of MIF 2nd day (t2) weresignificantly higher in patients with focal bacterial infection to those withsevere invasive bacterial infection and to those with viral infection orFUO (p=0,030). All the other markers had no prognostic value inidentifying severe bacterial infection. In the oncology patient group allfour markers increase from first (t0) to second (t2) measurement. NGAL measurements 2 days after admission (t2) were significantly highercomparing with those upon admission (p=0,002). In the control groupMIF increases and the other markers decrease between measurementswith no statistical significance. Between groups MIF and NGAL werehigher in the control group compared to the cancer group.Conclusion: Biochemical markers PCT and MIF have a significantprognostic value in identifying patients with high risk of severe bacterialinfection upon the onset of a febrile episode. Markers PCT and NGALhave a significant prognostic value in identifying patients with high riskof severe bacterial infection at the 2nd day of admission to the hospitalwith a febrile neutropenic episode. These markers seem to be useful inthe clinical management of pediatric cancer patients that present withfebrile neutropenia.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ορφανάκου, Αρχοντούλα
Subjects
dc:subject × 21- Εμπύρετη ουδετεροπενία
- Παιδιατρικός ογκολογικός πληθυσμός
- Καρκίνος και λοίμωξη
- Παιδί με καρκίνο και πυρετό
- Λοίμωξη και ουδετεροπενία
- Προκαλσιτονική σε εμπύρετη ουδετεροπενία
- Βιοχημικοί δείκτες
- Προγνωστική αξία
- Febrile neutropenia
- Pediatric oncology patients
- Cancer and infection
- PCT and CRP as markers
- Prognostic value of ngal and mif
- Serious bacterial infection
- Children with cancer and febrile neutropenia
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40525